insights_auto
Prečo akcie 0QF stúpli 5,06%?
Preskúmať podrobnejšiechevron_right
0QF:ETR
Moderna Inc
197,26 €
arrow_upward
+5,06%(+9,50) 1 d.
12. 10., 17:35:39 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 0QF…
Otvoriť
202,65 €
Vysoká
205,25 €
Nízka
197,18 €
Trh. kap.
85,66 mld.
Priem. obj.
28,88 tis.
Objem
48,97 tis.
Max. za 52 týž.
205,25 €
Min. za 52 týž.
19,37 €
Počet zamestnancov
5 tis.
Otvoriť
202,65 €
Vysoká
205,25 €
Nízka
197,18 €
Trh. kap.
85,66 mld.
Priem. obj.
28,88 tis.
Objem
48,97 tis.
Max. za 52 týž.
205,25 €
Min. za 52 týž.
19,37 €
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Quartz
·
pred 12 minútami
Moderna stock surges more than 600% in 2026
Investing.com
·
pred 39 minútami
Moderna technical outlook: bullish trend meets near-term pullback
Yahoo Finance
·
pred 3 hodinami
Moderna’s (MRNA) Cancer Vaccine Breakthrough Drives Sharp Stock Rally
FXLeaders
·
pred 5 hodinami
Moderna Stock Jumps 14% to 52-Week High Ahead of Detailed Melanoma Vaccine Data
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Informácie o subjekte Moderna Inc
Generálny riaditeľStéphane Bancel
Zamestnanci4,7 tis.
Dátum založeniasep 2010
Hlavné sídlo-
Odvetvie-